Chicago Trust’s Teladoc Health TDOC Stock Holding History

Chicago Trust’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,947	Closed	-$374K	–	350
2021 Q3	$374K	Buy	+2,947	New	+$429K	0.08%	231

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Chicago Trust's TDOC Position: Q4 2021 in Review

Chicago Trust sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 2,947 shares — an estimated $374K sold.

Chicago Trust first reported a position in TDOC in Q3 2021 and held it in 1 quarter. The position peaked at $374K in Q3 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

Chicago Trust reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
Chicago Trust sold 2,947 Teladoc Health shares in Q4 2021, an estimated $374K.
Chicago Trust first reported a position in Teladoc Health in Q3 2021 and held it in 1 quarter.
Chicago Trust's Teladoc Health position peaked at $374K in Q3 2021.
729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Chicago Trust's 13F filing for Q4 2021, filed 18 Jan 2022.